Pages that link to "Q31848173"
Jump to navigation
Jump to search
The following pages link to ST14A cells have properties of a medium-size spiny neuron. (Q31848173):
Displayed 40 items.
- Immortalization of neuronal progenitors using SV40 large T antigen and differentiation towards dopaminergic neurons (Q26829548) (← links)
- Intrabodies as neuroprotective therapeutics (Q27003896) (← links)
- AAV-dominant negative tumor necrosis factor (DN-TNF) gene transfer to the striatum does not rescue medium spiny neurons in the YAC128 mouse model of Huntington's disease (Q27334472) (← links)
- Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes (Q28189644) (← links)
- Inhibition of mitochondrial protein import by mutant huntingtin (Q28394803) (← links)
- Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model (Q28475537) (← links)
- Wnt signal pathways and neural stem cell differentiation (Q28566026) (← links)
- ErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1beta1-induced migration (Q28578116) (← links)
- Serine 421 regulates mutant huntingtin toxicity and clearance in mice. (Q30355064) (← links)
- Characterization of ST14A Cells for Studying Modulation of Voltage-Gated Calcium Channels. (Q30379878) (← links)
- Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm (Q30980477) (← links)
- An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity (Q33317678) (← links)
- Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity (Q33459255) (← links)
- Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors (Q33603921) (← links)
- Bifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragments (Q34117333) (← links)
- Differential nuclear localization of complexes may underlie in vivo intrabody efficacy in Huntington's disease (Q34313192) (← links)
- Modeling Huntington's disease in cells, flies, and mice (Q34408222) (← links)
- Characterization of mouse striatal precursor cell lines expressing functional dopamine receptors (Q35098204) (← links)
- Design and Evaluation of 3-(Benzylthio)benzamide Derivatives as Potent and Selective SIRT2 Inhibitors (Q35615138) (← links)
- Bifunctional Anti-Non-Amyloid Component α-Synuclein Nanobodies Are Protective In Situ (Q36185625) (← links)
- Regulation of feedback between protein kinase A and the proteasome system worsens Huntington's disease (Q36757044) (← links)
- Regulator of calcineurin (RCAN1-1L) is deficient in Huntington disease and protective against mutant huntingtin toxicity in vitro (Q37169441) (← links)
- Phosphorylation of threonine 3: implications for Huntingtin aggregation and neurotoxicity (Q37447680) (← links)
- The A2A adenosine receptor is a dual coding gene: a novel mechanism of gene usage and signal transduction. (Q37488413) (← links)
- Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease (Q37996350) (← links)
- Studying neurodegenerative diseases in culture models. (Q38165760) (← links)
- KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients (Q39375357) (← links)
- Necroptosis in neurodegenerative diseases: a potential therapeutic target (Q39404657) (← links)
- In vitro characterization of embryionic ST14A-cells (Q39929610) (← links)
- Systematic uncovering of multiple pathways underlying the pathology of Huntington disease by an acid-cleavable isotope-coded affinity tag approach (Q40175911) (← links)
- CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model. (Q40437569) (← links)
- Wnt-5a expression in the rat neuronal progenitor cell line ST14A. (Q40525752) (← links)
- Characterization of a p75(NTR) apoptotic signaling pathway using a novel cellular model (Q40792753) (← links)
- Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing (Q40817529) (← links)
- Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease (Q42626087) (← links)
- Gene expression profiling of ciliary neurotrophic factor-overexpressing rat striatal progenitor cells (ST14A) indicates improved stress response during the early stage of differentiation (Q44319940) (← links)
- Apoptosome inactivation rescues proneural and neural cells from neurodegeneration. (Q44981513) (← links)
- BDNF prevents NMDA-induced toxicity in models of Huntington's disease: the effects are genotype specific and adenosine A2A receptor is involved. (Q45291563) (← links)
- A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease (Q45305713) (← links)
- ST14A (Q54955742) (← links)